Treatment Sequencing and Unmet Needs in aRCC
ASCO® GU 2024 Insights: "Nivo + Cabozantinib vs. Sunitinib for Previously Untreated Advanced RCC - Results From 55-Month Follow-Up of the CheckMate 9ER Trial"
By
Insights from 2024 ASCO® GU Annual Meeting
FEATURING
Maria Bourlon
By
Insights from 2024 ASCO® GU Annual Meeting
FEATURING
Maria Bourlon
Login to view comments.
Click here to Login
